Coty (COTY) delivered a fiscal first-quarter beat. Adjusted EPS of $0.16 topped the $0.12 consensus by 33.3% and was up 33.3% year over year. Revenue of $1.555 billion exceeded the $1.53 billion estimate by 1.6%, although sales still fell 1.4% from a year ago. The more meaningful development is commercial: Coty's Top 6 core Prestige brands returned to growth for the first time in this recovery effort. The earnings line overstates how much profitability actually improved, and that gap is the central tension of the quarter. The top line is healing faster than the margin structure.

The quality of the beat deserves scrutiny. Adjusted EPS included a $0.01 benefit from the equity swap mark-to-market, compared with a $0.03 hit in the prior-year quarter. That swing accounts for the entire headline growth figure. Net interest expense also fell to $31.2 million from $46.6 million as debt came down. Operating results moved the other way. Adjusted operating income fell 8% to $220.5 million, and adjusted EBITDA declined 7% to $274.2 million, with margin down 120 basis points to 17.6%. Gross margin also contracted 120 basis points to 63.3%, worse than the 50-to-100-basis-point decline management had guided on the prior call. About 50 basis points came from Middle East-related freight and materials costs. The rest came from mix and higher excess-and-obsolescence charges. Consumer Beauty was the weak spot: it swung to a $15.0 million adjusted operating loss from a $1.5 million profit, and segment EBITDA fell 59%. Prestige adjusted operating income held roughly flat at a 22.3% margin, but only because lower advertising and promotional spending offset weaker gross margin.

The sales trajectory is where the story genuinely improved. Like-for-like sales declined 2%, compared with declines of 6% and 4% in the two halves of fiscal 2026. The Top 6 Prestige brands make up 73% of Prestige sales, and they swung from a 6% decline in the first half of fiscal 2026 to 5% growth. That figure deserves a caveat: management indicated growth was closer to 3% excluding pipeline fill for the Marc Jacobs Beauty makeup launch. Consumer Beauty's decline narrowed to 3% from 8%, and CoverGirl improved to roughly -2% from about -8%. U.S. prestige returned to growth and Asia Pacific rose 8% like-for-like, led by China. EMEA fell 5%, with Germany and France still soft and the Middle East weaker. The call carried a more confident tone, with management citing 'green shoots' and noting that all four major launches are tracking ahead of plan. Management was also explicit that sell-out still trails the market in both divisions.

The forward picture is mixed. On the positive side:

• The roughly 40-year Marc Jacobs license extension adds long-term visibility to the Prestige portfolio.
• Etro fragrances debut in the second half, and Swarovski follows in calendar 2027.
• A strategic review due by the end of calendar 2026 could reshape the portfolio.

On the negative side:

• Management raised its oil and input-cost headwind estimate to $30-40 million from $20-30 million. It flagged the upper end if crude stays above $100.
• Inventory rose to $874.5 million from $838.7 million, and management said the excess-and-obsolescence cleanup will take time.
• The Gucci Beauty exit removes a double-digit share of sales at roughly 70% gross margin. The savings plan meant to offset it is not due until around January.

Q2 guidance was in line rather than encouraging. Management expects a low-single-digit like-for-like decline, a high-single-digit drop in adjusted EBITDA, and adjusted EPS excluding the swap of $0.16 to $0.18. There is still no full-year outlook. The CEO remains interim and the CFO is new.

The balance sheet is the clearest near-term win. Free cash flow rose to $84.6 million from $11.2 million, helped by better payables and receivables. Together with $250 million of upfront Gucci proceeds, that cut financial net debt by more than $300 million since June, to $2.58 billion. Leverage now stands at 3.1 times adjusted EBITDA. Management reiterated first-half free cash flow of over $300 million.

The market setup is more complicated than the surprise implies. Shares have rallied 36.1% since the open after the August report and trade about 37% above their 200-day moving average. Price-based trend readings have turned positive alongside that move. Investor sentiment went the other way, falling from roughly -0.10 to about -0.25. That is a meaningful deterioration, not a collapse. The stock has already priced in a good deal of recovery while investors have grown more skeptical, and bears have legitimate ammunition in margin compression and the unquantified Gucci hole.

The bottom line is that Coty's quarter offered real evidence of a top-line turn in its core Prestige brands and a much healthier cash profile. The EPS beat, however, leaned on swap and interest tailwinds while operating profit kept shrinking. Until gross margin stabilizes, the Gucci offset is quantified, and the strategic review delivers a full-year framework, the recovery remains a credible work in progress rather than a proven earnings inflection.